Arcutis Biotherapeutics Inc is a biopharmaceutical firm dedicated to crafting and bringing to market treatments for skin conditions. With a leading product, ARQ-151, aimed at addressing plaque psoriasis and atopic dermatitis, the company is at the forefront of dermatological innovation. Their pipeline also includes solutions for scalp psoriasis, seborrheic dermatitis, hand eczema, vitiligo, and alopecia areata, showcasing their commitment to tackling a wide range of dermatological challenges. Founded in 2016 and based in Westlake Village, California, Arcutis is pushing the boundaries of skin health.